BioTools Innovator
Investors double down on AI drug development
Funding for artificial intelligence (AI) in drug development hit $4.1 billion in 2021, a 36% increase from the year before, according to Emersion Insights. The AI drug development industry has gained a lot of attention from investors, venture capital firms, and corporate investment funds in recent years. Read More
Pancreatic stellate cells promote cancer cell proliferation, tumor growth
Using optical imaging to study metabolic processes as they relate to tumor growth, researchers hope to better understand the tumor microenvironment and potential interventions. New research published on January 21 in Science Advances showed that pancreas cells co-cultured with pancreatic cancer cells in 3D organoids resulted in increased pancreatic cancer cell growth. Read More
Samsung Biologics reports Q4, 2021 fiscal year financial results
Samsung Biologics reported strong financial results for the fourth quarter and record high earnings for the 2021 fiscal year, achieving fourth quarter revenue of 444.3 billion South Korean won ($37 million U.S.), an increase of 18% from 375.3 billion South Korean won ($31 billion U.S.) reported for the fourth quarter last year. Read More
Illumina collaborates with National Cancer Center Japan
Illumina and National Cancer Center Japan are collaborating on an international joint research project that will use Illumina's high-throughput DNA sequencing to analyze the blood-based genomic profile and clinical information of patients living with nasopharyngeal carcinoma. Read More
Harbour BioMed successfully doses antiCTLA-4 antibody
Harbour BioMed has successfully completed dosing of the first patient in a phase IB/IIA trial at the stage of dose expansion of its anticytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody, HBM4003, in combination therapy with toripalimab, an antiprogrammed cell death protein 1 antibody, for patients suffering from advanced melanoma and solid tumors. Read More
Anixa Biosciences, MolGenie announce SARS-CoV-2 protease inhibitor
Anixa Biosciences and its partner MolGenie have synthesized a compound that appears to be considerably more potent than nirmatrelvir at inhibiting the main protease of the SARS-CoV-2 virus. Read More
NanoMosaic signs lease for multiomics HQ in Waltham, Mass.
NanoMosaic has signed a lease for a stand-alone building of 30,880 sq ft in Waltham, MA. NanoMosaic is a biotechnology company that pioneered nanoneedle (MosaicNeedle) technology detection for proteomics, genomics, and single-run experiment multiomics applications, alongside the development of assays for biomarker discovery and validation. Read More
Resilience key to success during pandemic and beyond
It has been a challenging past couple of years for the world with the pandemic impacting seemingly every aspect of life. Companies that have remained agile and dedicated to problem-solving have been able to weather the storm more easily compared to those that lacked strong contingency plans, according to Bryan Katz, senior vice president and global head of solution development at Syneos Health, who moderated a panel discussion at Biotech Showcase 2022. Read More
BD innovation highlights new flow cytometry tech
A new study conducted by Becton Dickinson (BD) in collaboration with the European Molecular Biology Laboratory, which was published as the cover story of Science on January 20, profiles a BD innovation in flow cytometry that adds fluorescence imaging and image-based decisioning to sort individual cells at an exceptionally high speed. Read More
BenchSci raises $63M Canadian dollars to expand AI-powered software platform
BenchSci, a developer of machine-learning applications for novel medicine development, has obtained $63 million Canadian dollars ($50 million) through a series C funding round. The funding will allow the company to expedite the expansion of its artificial intelligence (AI)-powered software platform. Read More
Conferences
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter